We suggest you to use Compugen Ltd fundamental analysis to see if markets are presently mispricing the company. In plain English you can use it to find out if Compugen Ltd is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. . We found twenty-six available fundamental indicators for Compugen Ltd which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Compugen Ltd fundamentals including its Revenue, EBITDA and the relationship between Price to Sales and Gross Profit . Use Compugen Ltd to protect your portfolios against small markets fluctuations. The stock experiences very speculative upward sentiment. Check odds of Compugen Ltd to be traded at S1128.6 in 30 days.
Chance of Financial Distress
Compugen Ltd has less than 2 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info
Compugen Ltd competes with Kamada Ltd, Clal Biotechnology, Pluristem Therapeutics, and BioLine Rx. Compugen Ltd., a therapeutic discovery company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel and Europe. The company was incorporated in 1993 and is headquartered in Holon, Israel. Compugen Ltd operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 89 people.
Compugen Ltd is rated fourth in working capital category among related companies. It is rated third in current valuation category among related companies reporting about 9.83 of Current Valuation per Working Capital.
Compugen Ltd Systematic Risk
The output start index for this execution was twenty-four with a total number of output elements of fifteen. The Beta measures systematic risk based on how returns on Compugen Ltd correlated with the market. If Beta is less than 0 Compugen Ltd generally moves in the opposite direction as compared to the market. If Compugen Ltd Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Compugen Ltd is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Compugen Ltd is generally in the same direction as the market. If Beta > 1 Compugen Ltd moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.